• Biosimilar infliximab introduction into the gastro-enterology care pathway in a large acute Irish teaching hospital: a story behind the evidence 

  O'Brien, Gary L.; Carrol, Donal; Mulcahy, Mark; Walshe, Valerie; Courtney, Garry; Byrne, Stephen (Pro Pharma Communications International, 2018-02-27)

  Background and aim: Biosimilar medicines are not considered exact replicas of originator biological medicines. As a result, prescribers can be hesitant to introduce such medicines into the clinical setting until evidence ...
• Cost-effectiveness analysis of a physician-implemented medication screening tool in older hospitalised patients in Ireland 

  O'Brien, Gary L.; O'Mahony, Denis; Gillespie, Paddy; Mulcahy, Mark; Walshe, Valerie; O'Connor, Marie N.; O'Sullivan, David; Gallagher, James; Byrne, Stephen (Springer International Publishing AG, 2018-07-13)

  Background: A recent randomised controlled trial conducted in an Irish University teaching hospital that evaluated a physician-implemented medication screening tool, demonstrated positive outcomes in terms of a reduction ...
• Parenteral protein formulations: an overview of approved products within the European Union 

  Gervasi, Valeria; Dall Agnol, R.; Cullen, S.; McCoy, T.; Vucen, Sonja; Crean, Abina M. (Elsevier B.V., 2018-07-11)

  The study presented is a comprehensive overview of commercial parenteral protein formulations, approved by the European Medicines Agency (EMA), 1995-2018. The objective of this overview was to analyse current trends in the ...
• Cocrystals and a salt of the bioactive flavonoid: naringenin 

  Khandavilli, Udaya Bhaskara Rao; Skořepová, Eliška; Sinha, Abhijeet S.; Bhogala, Balakrishna R.; Maguire, Nuala M.; Maguire, Anita R.; Lawrence, Simon E. (American Chemical Society, 2018-07-03)

  Cocrystallization studies on Naringenin with 27 coformers have led to the formation of five new solid forms: a piperazinium salt (PIP+-NR-) and four cocrystals with the coformers flavone (FLV), 4-hydroxypyridine (4-HP), ...
• Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells 

  Cambados, Nadia; Walther, Thomas; Nahmod, Karen; Tocci, Johanna M.; Rubinstein, Natalia; Boehme, Ilka; Simian, Marina; Sampayo, Rocio; Del Valle Suberbordes, Melisa; Kordon, Edith C.; Schere-Levy, Carolina (Impact Journals, 2017)

  Angiotensin (Ang) II, the main effector peptide of the renin-angiotensin system, has been implicated in multiple aspects of cancer progression such as proliferation, migration, invasion, angiogenesis and metastasis. ...

View more